Cavinton, 5 mg/ml 5 ml 10 pcs

A drug that improves cerebral blood flow and brain metabolism. Improves brain metabolism by increasing glucose and oxygen uptake by brain tissue.

Indications

Active ingredient

Composition

1 ml. contains vinpocetine 5 mg.

Supplementary substances:

ascorbic acid,

sodium disulfite,

tartaric acid,

benzyl alcohol,

sorbitol,

d/i water.

How to take, the dosage

The drug is intended for intravenous drip infusion. Administer slowly; the infusion rate should not exceed 80 drops/min.

The drug must not be administered by injection and IV without dilution.

Physiological solution or solutions containing dextrose (Salsol, Ringer, Rindex, Reomacrodex) can be used to prepare infusion. Infusion solution with Cavinton should be used in the first 3 hours after preparation.

The usual initial daily dose is 20-25 mg in 500 ml of infusion solution. Depending on tolerance, within 2-3 days the dose may be increased to no more than 1 mg/kg/day. The average duration of treatment is 10-14 days.

The average daily dose in case of body weight of 70 kg is 50 mg (in 500 ml of infusion solution).

Dose adjustment is not required in case of liver and kidney diseases.

At the end of the course of IV therapy it is recommended to continue treatment with tablets Kavinton Forte (1 tablet 3 times/day) or Kavinton (2 tablets 3 times/day).

Interaction

Special Instructions

Contraindications

Side effects

Cardiovascular system disorders: aggravation of existing arrhythmias is possible.

Digestive system disorders: nausea, heartburn, dry mouth.

CNS disorders: headache, dizziness, insomnia, weakness.

Allergic reactions: skin rash, urticaria.

Skin reactions: skin hyperemia.

Overdose

The data on overdose of Cavinton are currently limited.

Treatment: conduct symptomatic therapy.

Pregnancy use

The drug is contraindicated in pregnancy and lactation.

Similarities